Date: 4 November 2015
Organiser: Women's Health Concern
Location: Royal College of Obstetricians & Gynaecologists, London
THIS EVENT IS NOW PASSED
Join us for an interesting, informative and interactive day of women’s health updates from internationally-renowned experts
The Symposium format gives the opportunity to network with speakers and colleagues from Primary and Secondary care alike – and to raise queries, questions and seek advice from our expert panel, especially on difficult or complex cases.
Who should attend
GPs, clinic doctors, gynaecologists, trainees, specialist and practice nurses and anyone allied to the health profession with an interest in women’s health.
6 hours CPD/CME from the Faculty of Sexual and Reproductive Healthcare (FSRH).
Chaired by Dr John Stevenson, to include:
- Female Genital Mutilation, Miss Gubby Ayida
- Gerald Swyer Memorial Lecture, sponsored by Novo Nordisk: Are you up for it? Maintaining Sexual Function after the Menopause, Mr Tim Hillard
- Infertility, Mr Geoffrey Trew
- Beyond Cancer – Living with induced menopause, Mrs Kathy Abernethy
- Fibroids and Pelvic Health, sponsored by Gedeon Richter, Ms Anne Deans and Miss Erika Manzo
- Update on HRT and ovarian and breast cancer, Professor Richard Farmer
- NICE Guideline Menopause: diagnosis and management, Professor Mary Ann Lumsden
Enquiries to email@example.com
Sponsors of Fibroids and Pelvic Health, Ms Anne Deans and Miss Erika ManzoThe Women’s Health Division of Gedeon Richter (UK) Ltd is dedicated to the development and commercialisation of innovative drugs for women’s reproductive medicine.
With the vision of becoming a leading biopharmaceutical company in the field of women’s reproductive medicine, Women’s Health Division is focusing its R&D activities on developing non-invasive medical treatments for common, underserved gynaecological conditions. These have a severe impact on the patient’s life, in which current treatments remain unsatisfactory, and in many cases, have severe side effects. The company has a pipeline of innovative compounds which includes first in class molecules with development stages spanning from pre-clinical to newly licensed.
Sponsors of the Gerald Swyer Memorial Lecture: Are you up for it? Maintaining Sexual Function after the Menopause, Mr Tim Hillard
Novo Nordisk is a global healthcare company with more than 90 years of innovation and leadership in diabetes care. This heritage has given us experience and capabilities that also enable us to help people with other serious chronic conditions: haemophilia, growth disorders, the menopause and obesity. Headquartered in Denmark, Novo Nordisk employs approximately 39,000 people in 75 countries and markets its products in more than 180 countries.
Full programme/registration [335KB, PDF]
Meeting info [78KB, PDF]
Speakers [124KB, PDF]
Programme [150KB, PDF]
Registration form [86KB, PDF]
Delegate feedback from 2014 Women’s Health Symposium:
“I choose this meeting every year over other meetings as the subject and speakers are always excellent.”
“This year was as good as always. Very topical, not too scientific but clinically relevant. Very helpful.”
“Panel Q & A session was particularly useful. Some very practical tips for General Practice.”
“As always a very enjoyable and informative symposium”
“Excellent venue and well organised. Good speakers and variety of topics. Good exhibition with knowledgeable and helpful reps.”
“Very interesting. Good range of topics. Excellent speakers. Very good practical tips.”
“Very informative. Very interesting and useful.”
“Great venue. Very good day.”
“Overall excellent day. Food & facilities also super. Thank you to all involved in making the day such a success.”
“Good day! Good relevant topics. Good presentations.”